Hiroaki Takakura
Overview
Explore the profile of Hiroaki Takakura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirose T, Kunisada Y, Kadoya K, Mandai H, Sakamoto Y, Obata K, et al.
Cancer Genomics Proteomics
. 2024 Aug;
21(5):464-473.
PMID: 39191499
Background/aim: Malignant melanoma is a tumor with a poor prognosis that can metastasize distally at an early stage. Terrein, a metabolite produced by Aspergillus terreus, suppresses the expression of angiogenin,...
2.
Takakura H, Domae S, Ono T, Sasaki A
Acta Med Okayama
. 2017 Jun;
71(3):219-226.
PMID: 28655941
Anticancer drugs induce cell-cycle arrest and apoptosis not only in tumor cells, but also in immune cells. However, many preclinical and clinical findings show that some chemotherapeutic agents can improve...
3.
Murakami T, Fujii A, Kawabata Y, Takakura H, Yamaue R, Balam T, et al.
Acta Med Okayama
. 2013 Oct;
67(5):277-83.
PMID: 24145727
The aims of this study were to investigate how the Peer Assessment Rating (PAR index) predicts the perceived need for orthodontic treatment of mandibular protrusion in Japanese subjects, and to...
4.
Araki K, Takakura H, Miyajima Y, Akashi Y, Kawanishi K, Kakita S, et al.
J Gen Appl Microbiol
. 2002 Dec;
45(4):169-176.
PMID: 12501374
During a study on the effect of DL-serine hydroxamate on Corynebacterium glutamicum (JCM1318, a wild strain), a mutant resistant to the drug, strain TO3002, was isolated. This mutant accumulated five...